Search

Eli Lilly has paused its obesity awareness campaign in India after receiving a warning from the country's drugs regulator that the campaign could violate rules against indirectly advertising prescription medications to consumers, despite the campaign being aimed at reframing obesity as a chronic disease without mentioning specific products. #ObesityAwareness #PharmaceuticalRegulation #HealthCampaigns #IN #US #DK